Web Content Management
PRODUCTS
-
This easy-to-use process analytical technology device offers in-line bioprocess analysis and control with no complex modeling. Measure multiple critical parameters across media, across processes, across mammalian cell lines, across scales.
All In-line Gain, No Modeling Pain
MAVERICK is powered by Raman spectroscopy and a purpose-built de novo model. The de novo model is explicitly built on media chemistries and device physics, not on empirical data. It automatically interprets the spectra and quantifies process parameters enabling simultaneous measurements of glucose, lactate, and total biomass. This is achieved without the costs, complexities, and risks associated with conventional Process Analytical Technology (PAT) methods. There is no need to grapple with complex empirical models, reagents, or unreliable auto-sampling systems to implement in-line bioprocess analysis.
-
Planning to launch a patient-centric decentralized clinical trial? Give your clinical trial patients an app that makes it easy to participate—from anywhere at any time.
Simplify clinical trial participation with an integrated eCOA and ePRO solution
TrialKit’s electronic clinical outcome assessment (eCOA) and electronic patient-reported outcomes (ePRO) platform integrates with all currently available wearables, mobile operating systems, and web applications. Whether you collect data in the clinic, with provisioned devices, or take a bring-your-own-device (BYOD) approach, you can count on seamless data sharing and efficient study execution.
-
Altasciences’ experienced team specializes in early-phase renal and hepatic impairment studies, delivering tailored clinical pharmacology trials that support your regulatory submissions.
-
Navigating the technical challenges of mAbs production and scalability
Monoclonal antibodies (mAbs) offer promising immunotherapy treatments, targeting antigens and diseases. Manufacturing these complex therapies presents challenges in scaling up, cost, and consistency. Germfree’s expertise in tailored cleanroom solutions addresses these obstacles, ensuring sterility and seamless equipment integration. By providing advanced facilities for both small-scale clinical trials and larger-scale production, Germfree contributes to the successful development and commercialization of mAbs, ultimately improving patient outcomes and transforming healthcare landscapes.
-
Gain human-relevant insights with patient-derived assay-ready organoids.
WHITE PAPERS AND CASE STUDIES
-
Sustainable Solutions For Medical Devices
Explore how medical device companies aim to balance patient safety with environmental stability by offering bio-based UHMWPE, which reduces carbon footprints by up to 70%.
-
Driving Customer Profitability With Enterprise Platform, Pricing
Explore how the solutions and approaches offered by CDS can help different research stakeholders conduct more cost-efficient clinical trials in the industry's pharmaceutical, biotech, and device sectors.
-
Economic Advantage Of Robotic Gloveless Pharmaceutical Isolators
Are robotic gloveless isolators the key to smarter, safer, scalable solutions? Discover how they can revolutionize aseptic filling by reducing contamination, minimizing waste, and enhancing manufacturing flexibility.
-
Accelerating Cold Chain Expansion: Responding To COVID-19 Challenges
Review how leveraging cross-functional teamwork helped complete a cold chain infrastructure expansion in a fraction of the expected timeline, ensuring the production of essential COVID-19 therapeutics.
-
Improving Patient Health And Safety: Medical Affairs
A medical affairs department needed leaders with scientific and project management expertise. With no time for training or risk tolerance, a consultant was hired to align activities with development and launch plans.
-
PlantPAx Distributed Control System Reduces Downtime For Mallinckrodt
Learn how the nation's leading supplier in prescription pain medication completely upgraded their control system, resulting in greater diagnostic/troubleshooting information and reducing downtime.
-
eCOA: Unified Approach Streamlines Processes, Speeds Start Up And Improves Data Quality
Discover how a leading biopharmaceutical company revolutionized its clinical development with an eCOA solution that optimized its processes, cut build times, and enhanced data quality.
-
What Provided Critical Reagents To The COVID-19 Pandemic Response?
Typically, mAb manufacturing takes up to 60 days due to demand and outsourcing lags. Instead, imagine a unified platform that can deliver your mAb in 18 days.
-
Could RFID-Based Unit-Level Traceability Be Key To Operational Excellence?
Radiofrequency identification (RFID)-based unit-level tracking solutions for prefilled syringes are poised to help pharma manufacturers address key risks and costly bottlenecks related to the fill-finish process.
-
Quattrone Develops Cost-Efficient Stormwater Network Solution For New Housing Complex In Florida
In this case study, read about how using OpenFlows StormCAD saved $10,000 and avoided a potential six-month construction delay.
-
PFAS Removal System Proven Effective In Removing Both Long And Short Chain PFAS
A new system removed all nine PFAS compounds from a municipality's water to non-detect levels in a single pass. Unlike traditional methods, it addresses both long- and short-chain PFAS while generating minimal waste.
-
Advancing From Single Country Phase 1 Success To Multinational Phase 1/2 Trial
Explore how this partnership aims to contribute to the success of the trial by leveraging global resources and streamlining processes for efficient and timely results.
NEWS
-
Athelas Strengthens Market Leadership In Strategic Partnership With Resilient Healthcare3/7/2025
Athelas, powered by Commure, announced a strategic partnership with Resilient Healthcare Corp, a trailblazer in health-at-home solutions, to launch a groundbreaking pilot program aimed at revolutionizing outpatient care and hospital billing.
-
Yorkshire Water Models Sewer Data Availability10/2/2025
An ongoing project with Yorkshire Water is taking a proactive approach to combined sewer overflow (CSO) management, shifting from reactive responses to preventative measures - crucial for both regulatory compliance and environmental protection.
-
SoftServe Unveils New Gen AI Solution 'Drug Discovery,' Built With NVIDIA Blueprints At AWS Re:Invent 202412/3/2024
SoftServe, a premier IT consulting and digital services provider, today announced the debut of its newest Generative AI (Gen AI) solution, Drug Discovery, alongside its partner NVIDIA at AWS re:Invent 2024.
-
New Cancer Drug Boosts Effectiveness Of Chemotherapy – Even In Resistant Tumours8/11/2025
A groundbreaking cancer drug could enhance how patients respond to chemotherapy even in treatment-resistant tumours.
-
Daxor Expands To Three New Facilities As Blood Volume Analysis Technology Gains Momentum Nationwide8/5/2024
Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces the expansion of blood volume analysis (BVA) in three new facilities.